Benfotiamine Enters Phase 2 Trial as Novel Alzheimer's Treatment
A Phase 2A-2B clinical trial, Benfoteam, is underway to evaluate benfotiamine, a thiamine precursor, for slowing Alzheimer's progression in patients with mild cognitive impairment or mild dementia.
National Clinical Trial Investigates Benfotiamine for Early Alzheimer's Disease
A nationwide Phase 2A-2B clinical trial, named BenfoTeam, is underway to assess benfotiamine, a synthetic form of vitamin B1, for treating mild cognitive impairment and early Alzheimer's disease.
© Copyright 2025. All Rights Reserved by MedPath